A Primer On The Hepatitis C Market Submitted by admin on Fri, 07/04/2014 - 11:53 Read more about A Primer On The Hepatitis C Market Source Yahoo/Investors Business Daily Headline A Primer On The Hepatitis C Market News Tags hepatitis C Gilead Sovaldi Merck Victrelis Incivek Vertex Pharmaceuticals Olysio JNJ AbbVie Indenix Bristol-Myers Squibb
Achillion May Be The Most Underrated Biotech Left Submitted by admin on Wed, 06/26/2013 - 09:35 Read more about Achillion May Be The Most Underrated Biotech Left Source Seeking Alpha Headline Achillion May Be The Most Underrated Biotech Left News Tags Achillion AbbVie Bristol-Myers Squibb Gilead Vertex Pharmaceuticals Indenix ACH-3102 ACH-1625 hepatitis C
Buyout Buzz: The most frequently cited takeover targets in biotech Submitted by admin on Tue, 11/06/2012 - 16:32 Read more about Buyout Buzz: The most frequently cited takeover targets in biotech Source Fierce Biotech Headline Buyout Buzz: The most frequently cited takeover targets in biotech News Tags biotech M&A Amarin Achillion ONYX Pharmaceuticals Actelion Elan Forest Labs Medivation Biomarin Indenix
Idenix tumbles on hepatitis drug safety concerns Submitted by admin on Thu, 08/16/2012 - 11:54 Read more about Idenix tumbles on hepatitis drug safety concerns Source Yahoo/AP Headline Idenix tumbles on hepatitis drug safety concerns News Tags Indenix hepatitis C IDX184
IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection Submitted by admin on Wed, 07/25/2012 - 09:37 Read more about IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection Source Yahoo Headline IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chroni… News Tags IDX719 fast track FDA Chronic Hepatitis C hepatitis C Indenix
Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug Submitted by admin on Wed, 06/20/2012 - 11:50 Read more about Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug Source Seeking Alpha Headline Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug News Tags Indenix hepatitis C IDX184
Keryx and Peers are Strong Buys Submitted by admin on Tue, 05/29/2012 - 11:14 Read more about Keryx and Peers are Strong Buys Source Motley Fool Headline Keryx and Peers are Strong Buys News Tags Keryx Arena Pharmaceuticals Dendreon Novartis Indenix Spectrum Pharmaceuticals
Vertex Hopes Two Cystic Fibrosis Drugs Better than One Submitted by admin on Tue, 04/24/2012 - 10:36 Read more about Vertex Hopes Two Cystic Fibrosis Drugs Better than One Source TheStreet.com Headline Vertex Hopes Two Cystic Fibrosis Drugs Better than One News Tags cystic fibrosis Vertex Gilead Bristol-Myers Squibb Indenix Kalydeco VX-809
Why Idenix Pharmaceuticals Could Dive Further Submitted by admin on Fri, 04/13/2012 - 08:26 Read more about Why Idenix Pharmaceuticals Could Dive Further Source Motley Fool Headline Why Idenix Pharmaceuticals Could Dive Further News Tags Indenix IDX184 hepatitis C
Bio-Pharma Watch List: 2 Week Report Card Submitted by admin on Mon, 03/12/2012 - 17:30 Read more about Bio-Pharma Watch List: 2 Week Report Card Source Seeking Alpha Headline Bio-Pharma Watch List: 2 Week Report Card News Tags Spectrum Pharmaceuticals Acadia Antares Pharma BioSante Indenix